These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 15647826

  • 1. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX, Schneider A, Jung Y, Wang J, Dai J, Wang J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, Keller ET, McCauley LK, Taichman RS.
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [Abstract] [Full Text] [Related]

  • 2. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML.
    Prostate; 2006 Jan 01; 66(1):32-48. PubMed ID: 16114056
    [Abstract] [Full Text] [Related]

  • 3. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, Usui T, Kamiya K.
    Biochem Biophys Res Commun; 2004 Jul 30; 320(3):656-63. PubMed ID: 15240098
    [Abstract] [Full Text] [Related]

  • 4. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ.
    Stem Cells; 2005 Aug 30; 23(7):879-94. PubMed ID: 15888687
    [Abstract] [Full Text] [Related]

  • 5. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL, Zhang JL, Tang SF, Fu QY, Li ZT.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 15; 88(3):202-5. PubMed ID: 18361822
    [Abstract] [Full Text] [Related]

  • 6. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Beider K, Avniel S, Kasem S, Galun E, Peled A.
    FASEB J; 2004 Aug 15; 18(11):1240-2. PubMed ID: 15180966
    [Abstract] [Full Text] [Related]

  • 7. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer].
    Ding YL, Fu QY, Tang SF, Zhang JL, Li ZY, Li ZT.
    Zhonghua Wai Ke Za Zhi; 2009 Feb 01; 47(3):210-3. PubMed ID: 19563077
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
    Perissinotto E, Cavalloni G, Leone F, Fonsato V, Mitola S, Grignani G, Surrenti N, Sangiolo D, Bussolino F, Piacibello W, Aglietta M.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):490-7. PubMed ID: 15701832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, Omata M.
    Cancer Res; 2005 Jul 01; 65(13):5864-71. PubMed ID: 15994964
    [Abstract] [Full Text] [Related]

  • 12. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C, Cui GH, Liu F, Wu QL, Chen Y.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):695-7. PubMed ID: 17553309
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC.
    Cancer Res; 2005 Nov 01; 65(21):9891-8. PubMed ID: 16267013
    [Abstract] [Full Text] [Related]

  • 14. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
    Zeelenberg IS, Ruuls-Van Stalle L, Roos E.
    Cancer Res; 2003 Jul 01; 63(13):3833-9. PubMed ID: 12839981
    [Abstract] [Full Text] [Related]

  • 15. Role of CXCL12 in metastasis of human ovarian cancer.
    Jiang YP, Wu XH, Xing HY, DU XY.
    Chin Med J (Engl); 2007 Jul 20; 120(14):1251-5. PubMed ID: 17697577
    [Abstract] [Full Text] [Related]

  • 16. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
    Chu H, Zhou H, Liu Y, Liu X, Hu Y, Zhang J.
    Int J Biochem Cell Biol; 2007 Jul 20; 39(1):197-205. PubMed ID: 16973405
    [Abstract] [Full Text] [Related]

  • 17. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.
    Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC.
    Nat Med; 2004 Aug 20; 10(8):858-64. PubMed ID: 15235597
    [Abstract] [Full Text] [Related]

  • 18. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H, Lau SK, Devi S, Yoon Y, Cho HT, Liang Z.
    Biochem Biophys Res Commun; 2006 Jul 21; 346(1):252-8. PubMed ID: 16756955
    [Abstract] [Full Text] [Related]

  • 19. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H, Mansel RE, Jiang WG.
    Int J Oncol; 2005 May 21; 26(5):1429-34. PubMed ID: 15809737
    [Abstract] [Full Text] [Related]

  • 20. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
    Van Overstraeten-Schlögel N, Beguin Y, Gothot A.
    Eur J Haematol; 2006 Jun 21; 76(6):488-93. PubMed ID: 16494621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.